Cell-mediated immune responses to respiratory syncytial virus infection

References

• Hall CB. Respiratory syncytial virus and parainfluenza virus. N Engl J Med 2001; 344:1917 - 28; http://dx.doi.org/10.1056/NEJM200106213442507; PMID: 11419430
   PubMed Web of Science ®Google Scholar
• Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, O’Brien KL, Roca A, Wright PF, Bruce N, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 2010; 375:1545 - 55; http://dx.doi.org/10.1016/S0140-6736(10)60206-1; PMID: 20399493
   PubMed Web of Science ®Google Scholar
• Widmer K, Zhu Y, Williams JV, Griffin MR, Edwards KM, Talbot HK. Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults. J Infect Dis 2012; 206:56 - 62; http://dx.doi.org/10.1093/infdis/jis309; PMID: 22529314
   PubMed Web of Science ®Google Scholar
• Karron RA, Wright PF, Belshe RB, Thumar B, Casey R, Newman F, Polack FP, Randolph VB, Deatly A, Hackell J, et al. Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants. J Infect Dis 2005; 191:1093 - 104; http://dx.doi.org/10.1086/427813; PMID: 15747245
   PubMed Web of Science ®Google Scholar
• Wright PF, Karron RA, Belshe RB, Thompson J, Crowe JE Jr., Boyce TG, Halburnt LL, Reed GW, Whitehead SS, Anderson EL, et al. Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy. J Infect Dis 2000; 182:1331 - 42; http://dx.doi.org/10.1086/315859; PMID: 11010838
   PubMed Web of Science ®Google Scholar
• Johnson TR, Graham BS. Secreted respiratory syncytial virus G glycoprotein induces interleukin-5 (IL-5), IL-13, and eosinophilia by an IL-4-independent mechanism. J Virol 1999; 73:8485 - 95; PMID: 10482601
   PubMed Web of Science ®Google Scholar
• Johnson TR, Teng MN, Collins PL, Graham BS. Respiratory syncytial virus (RSV) G glycoprotein is not necessary for vaccine-enhanced disease induced by immunization with formalin-inactivated RSV. J Virol 2004; 78:6024 - 32; http://dx.doi.org/10.1128/JVI.78.11.6024-6032.2004; PMID: 15141000
   PubMed Web of Science ®Google Scholar
• Jabeen R, Kaplan MH. The symphony of the ninth: the development and function of Th9 cells. Curr Opin Immunol 2012; 24:303 - 7; http://dx.doi.org/10.1016/j.coi.2012.02.001; PMID: 22365614
   PubMed Web of Science ®Google Scholar
• Stassen M, Schmitt E, Bopp T. From interleukin-9 to T helper 9 cells. Ann N Y Acad Sci 2012; 1247:56 - 68; http://dx.doi.org/10.1111/j.1749-6632.2011.06351.x; PMID: 22235761
   PubMed Web of Science ®Google Scholar
• Stockinger B, Veldhoen M. Differentiation and function of Th17 T cells. Curr Opin Immunol 2007; 19:281 - 6; http://dx.doi.org/10.1016/j.coi.2007.04.005; PMID: 17433650
   PubMed Web of Science ®Google Scholar
• Wang YH, Voo KS, Liu B, Chen CY, Uygungil B, Spoede W, Bernstein JA, Huston DP, Liu YJ. A novel subset of CD4(+) T(H)2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma. J Exp Med 2010; 207:2479 - 91; http://dx.doi.org/10.1084/jem.20101376; PMID: 20921287
   PubMed Web of Science ®Google Scholar
• Eyerich S, Eyerich K, Pennino D, Carbone T, Nasorri F, Pallotta S, Cianfarani F, Odorisio T, Traidl-Hoffmann C, Behrendt H, et al. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest 2009; 119:3573 - 85; PMID: 19920355
   PubMed Web of Science ®Google Scholar
• Zhang N, Pan HF, Ye DQ. Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention. Mol Cell Biochem 2011; 353:41 - 6; http://dx.doi.org/10.1007/s11010-011-0772-y; PMID: 21384158
   PubMed Web of Science ®Google Scholar
• Zielinski CE, Mele F, Aschenbrenner D, Jarrossay D, Ronchi F, Gattorno M, Monticelli S, Lanzavecchia A, Sallusto F. Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β. Nature 2012; 484:514 - 8; http://dx.doi.org/10.1038/nature10957; PMID: 22466287
   PubMed Web of Science ®Google Scholar
• Bettelli E, Korn T, Oukka M, Kuchroo VK. Induction and effector functions of T(H)17 cells. Nature 2008; 453:1051 - 7; http://dx.doi.org/10.1038/nature07036; PMID: 18563156
   PubMed Web of Science ®Google Scholar
• Collins PL, Graham BS. Viral and host factors in human respiratory syncytial virus pathogenesis. J Virol 2008; 82:2040 - 55; http://dx.doi.org/10.1128/JVI.01625-07; PMID: 17928346
   PubMed Web of Science ®Google Scholar
• van Drunen Littel-van den Hurk S, Mapletoft JW, Arsic N, Kovacs-Nolan J. Immunopathology of RSV infection: prospects for developing vaccines without this complication. Rev Med Virol 2007; 17:5 - 34; http://dx.doi.org/10.1002/rmv.518; PMID: 17004293
   PubMed Web of Science ®Google Scholar
• Oshansky CM, Zhang W, Moore E, Tripp RA. The host response and molecular pathogenesis associated with respiratory syncytial virus infection. Future Microbiol 2009; 4:279 - 97; http://dx.doi.org/10.2217/fmb.09.1; PMID: 19327115
   PubMed Web of Science ®Google Scholar
• Stevens WW, Sun J, Castillo JP, Braciale TJ. Pulmonary eosinophilia is attenuated by early responding CD8(+) memory T cells in a murine model of RSV vaccine-enhanced disease. Viral Immunol 2009; 22:243 - 51; http://dx.doi.org/10.1089/vim.2009.0016; PMID: 19594395
   PubMed Web of Science ®Google Scholar
• Dodd JS, Lum E, Goulding J, Muir R, Van Snick J, Openshaw PJ. IL-9 regulates pathology during primary and memory responses to respiratory syncytial virus infection. J Immunol 2009; 183:7006 - 13; http://dx.doi.org/10.4049/jimmunol.0900085; PMID: 19915054
   PubMed Web of Science ®Google Scholar
• McNamara PS, Flanagan BF, Baldwin LM, Newland P, Hart CA, Smyth RL. Interleukin 9 production in the lungs of infants with severe respiratory syncytial virus bronchiolitis. Lancet 2004; 363:1031 - 7; http://dx.doi.org/10.1016/S0140-6736(04)15838-8; PMID: 15051283
   PubMed Web of Science ®Google Scholar
• Xing J, Wu Y, Ni B. Th9: a new player in asthma pathogenesis?. J Asthma 2011; 48:115 - 25; http://dx.doi.org/10.3109/02770903.2011.554944; PMID: 21294663
   PubMed Web of Science ®Google Scholar
• Blanco JC, Boukhvalova MS, Shirey KA, Prince GA, Vogel SN. New insights for development of a safe and protective RSV vaccine. Hum Vaccin 2010; 6:482 - 92; http://dx.doi.org/10.4161/hv.6.6.11562; PMID: 20671419
   PubMed Web of Science ®Google Scholar
• Shimbara A, Christodoulopoulos P, Soussi-Gounni A, Olivenstein R, Nakamura Y, Levitt RC, Nicolaides NC, Holroyd KJ, Tsicopoulos A, Lafitte JJ, et al. IL-9 and its receptor in allergic and nonallergic lung disease: increased expression in asthma. J Allergy Clin Immunol 2000; 105:108 - 15; http://dx.doi.org/10.1016/S0091-6749(00)90185-4; PMID: 10629460
   PubMed Web of Science ®Google Scholar
• Levitt RC, McLane MP, MacDonald D, Ferrante V, Weiss C, Zhou T, Holroyd KJ, Nicolaides NC. IL-9 pathway in asthma: new therapeutic targets for allergic inflammatory disorders. J Allergy Clin Immunol 1999; 103:S485 - 91; http://dx.doi.org/10.1016/S0091-6749(99)70165-X; PMID: 10329852
   PubMed Web of Science ®Google Scholar
• Mesquita D Jr., Cruvinel WM, Câmara NO, Kállas EG, Andrade LE. Autoimmune diseases in the TH17 era. Braz J Med Biol Res 2009; 42:476 - 86; http://dx.doi.org/10.1590/S0100-879X2009000600002; PMID: 19448894
   PubMed Web of Science ®Google Scholar
• Hou W, Kang HS, Kim BS. Th17 cells enhance viral persistence and inhibit T cell cytotoxicity in a model of chronic virus infection. J Exp Med 2009; 206:313 - 28; http://dx.doi.org/10.1084/jem.20082030; PMID: 19204109
   PubMed Web of Science ®Google Scholar
• Kohyama S, Ohno S, Isoda A, Moriya O, Belladonna ML, Hayashi H, Iwakura Y, Yoshimoto T, Akatsuka T, Matsui M. IL-23 enhances host defense against vaccinia virus infection via a mechanism partly involving IL-17. J Immunol 2007; 179:3917 - 25; PMID: 17785829
   PubMed Web of Science ®Google Scholar
• Román M, Calhoun WJ, Hinton KL, Avendaño LF, Simon V, Escobar AM, Gaggero A, Díaz PV. Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response. Am J Respir Crit Care Med 1997; 156:190 - 5; http://dx.doi.org/10.1164/ajrccm.156.1.9611050; PMID: 9230746
   PubMed Web of Science ®Google Scholar
• Bueno SM, González PA, Cautivo KM, Mora JE, Leiva ED, Tobar HE, Fennelly GJ, Eugenin EA, Jacobs WR Jr., Riedel CA, et al. Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG. Proc Natl Acad Sci U S A 2008; 105:20822 - 7; http://dx.doi.org/10.1073/pnas.0806244105; PMID: 19075247
   PubMed Web of Science ®Google Scholar
• Olson MR, Hartwig SM, Varga SM. The number of respiratory syncytial virus (RSV)-specific memory CD8 T cells in the lung is critical for their ability to inhibit RSV vaccine-enhanced pulmonary eosinophilia. J Immunol 2008; 181:7958 - 68; PMID: 19017987
   PubMed Web of Science ®Google Scholar
• Castilow EM, Olson MR, Meyerholz DK, Varga SM. Differential role of gamma interferon in inhibiting pulmonary eosinophilia and exacerbating systemic disease in fusion protein-immunized mice undergoing challenge infection with respiratory syncytial virus. J Virol 2008; 82:2196 - 207; http://dx.doi.org/10.1128/JVI.01949-07; PMID: 18094193
   PubMed Web of Science ®Google Scholar
• Lee YM, Miyahara N, Takeda K, Prpich J, Oh A, Balhorn A, Joetham A, Gelfand EW, Dakhama A. IFN-gamma production during initial infection determines the outcome of reinfection with respiratory syncytial virus. Am J Respir Crit Care Med 2008; 177:208 - 18; http://dx.doi.org/10.1164/rccm.200612-1890OC; PMID: 17962634
   PubMed Web of Science ®Google Scholar
• Becker Y. Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy--a review. Virus Genes 2006; 33:235 - 52; PMID: 16972040
   PubMed Web of Science ®Google Scholar
• Anderson LJ, Tsou C, Potter C, Keyserling HL, Smith TF, Ananaba G, Bangham CR. Cytokine response to respiratory syncytial virus stimulation of human peripheral blood mononuclear cells. J Infect Dis 1994; 170:1201 - 8; http://dx.doi.org/10.1093/infdis/170.5.1201; PMID: 7963714
   PubMed Web of Science ®Google Scholar
• Bont L, Heijnen CJ, Kavelaars A, van Aalderen WM, Brus F, Draaisma JM, Pekelharing-Berghuis M, van Diemen-Steenvoorde RA, Kimpen JL. Local interferon-gamma levels during respiratory syncytial virus lower respiratory tract infection are associated with disease severity. J Infect Dis 2001; 184:355 - 8; http://dx.doi.org/10.1086/322035; PMID: 11443563
   PubMed Web of Science ®Google Scholar
• Bendelja K, Gagro A, Bace A, Lokar-Kolbas R, Krsulovic-Hresic V, Drazenovic V, Mlinaric-Galinovic G, Rabatic S. Predominant type-2 response in infants with respiratory syncytial virus (RSV) infection demonstrated by cytokine flow cytometry. Clin Exp Immunol 2000; 121:332 - 8; http://dx.doi.org/10.1046/j.1365-2249.2000.01297.x; PMID: 10931150
   PubMed Web of Science ®Google Scholar
• Chen ZM, Mao JH, Du LZ, Tang YM. Association of cytokine responses with disease severity in infants with respiratory syncytial virus infection. Acta Paediatr 2002; 91:914 - 22; http://dx.doi.org/10.1111/j.1651-2227.2002.tb02877.x; PMID: 12412865
   PubMed Web of Science ®Google Scholar
• Tripp RA, Moore D, Barskey A 4th, Jones L, Moscatiello C, Keyserling H, Anderson LJ. Peripheral blood mononuclear cells from infants hospitalized because of respiratory syncytial virus infection express T helper-1 and T helper-2 cytokines and CC chemokine messenger RNA. J Infect Dis 2002; 185:1388 - 94; http://dx.doi.org/10.1086/340505; PMID: 11992272
   PubMed Web of Science ®Google Scholar
• Guo H, Topham DJ. Interleukin-22 (IL-22) production by pulmonary Natural Killer cells and the potential role of IL-22 during primary influenza virus infection. J Virol 2010; 84:7750 - 9; http://dx.doi.org/10.1128/JVI.00187-10; PMID: 20504940
   PubMed Web of Science ®Google Scholar
• Taube C, Tertilt C, Gyülveszi G, Dehzad N, Kreymborg K, Schneeweiss K, Michel E, Reuter S, Renauld JC, Arnold-Schild D, et al. IL-22 is produced by innate lymphoid cells and limits inflammation in allergic airway disease. PLoS One 2011; 6:e21799; http://dx.doi.org/10.1371/journal.pone.0021799; PMID: 21789181
   PubMed Web of Science ®Google Scholar
• Eyerich S, Wagener J, Wenzel V, Scarponi C, Pennino D, Albanesi C, Schaller M, Behrendt H, Ring J, Schmidt-Weber CB, et al. IL-22 and TNF-α represent a key cytokine combination for epidermal integrity during infection with Candida albicans. Eur J Immunol 2011; 41:1894 - 901; http://dx.doi.org/10.1002/eji.201041197; PMID: 21469124
   PubMed Web of Science ®Google Scholar
• Castilow EM, Meyerholz DK, Varga SM. IL-13 is required for eosinophil entry into the lung during respiratory syncytial virus vaccine-enhanced disease. J Immunol 2008; 180:2376 - 84; PMID: 18250447
   PubMed Web of Science ®Google Scholar
• Legg JP, Hussain IR, Warner JA, Johnston SL, Warner JO. Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 2003; 168:633 - 9; http://dx.doi.org/10.1164/rccm.200210-1148OC; PMID: 12773328
   PubMed Web of Science ®Google Scholar
• Lukacs NW, Tekkanat KK, Berlin A, Hogaboam CM, Miller A, Evanoff H, Lincoln P, Maassab H. Respiratory syncytial virus predisposes mice to augmented allergic airway responses via IL-13-mediated mechanisms. J Immunol 2001; 167:1060 - 5; PMID: 11441116
   PubMed Web of Science ®Google Scholar
• Nicolaides NC, Holroyd KJ, Ewart SL, Eleff SM, Kiser MB, Dragwa CR, Sullivan CD, Grasso L, Zhang LY, Messler CJ, et al. Interleukin 9: a candidate gene for asthma. Proc Natl Acad Sci U S A 1997; 94:13175 - 80; http://dx.doi.org/10.1073/pnas.94.24.13175; PMID: 9371819
   PubMed Web of Science ®Google Scholar
• Soussi-Gounni A, Kontolemos M, Hamid Q. Role of IL-9 in the pathophysiology of allergic diseases. J Allergy Clin Immunol 2001; 107:575 - 82; http://dx.doi.org/10.1067/mai.2001.114238; PMID: 11295641
   PubMed Web of Science ®Google Scholar
• Semple MG, Dankert HM, Ebrahimi B, Correia JB, Booth JA, Stewart JP, Smyth RL, Hart CA. Severe respiratory syncytial virus bronchiolitis in infants is associated with reduced airway interferon gamma and substance P. PLoS One 2007; 2:e1038; http://dx.doi.org/10.1371/journal.pone.0001038; PMID: 17940602
   PubMedGoogle Scholar
• Culley FJ, Pollott J, Openshaw PJ. Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood. J Exp Med 2002; 196:1381 - 6; http://dx.doi.org/10.1084/jem.20020943; PMID: 12438429
   PubMed Web of Science ®Google Scholar
• Weinberg A, Song LY, Wilkening C, Sevin A, Blais B, Louzao R, Stein D, Defechereux P, Durand D, Riedel E, et al, Pediatric ACTG Cryopreservation Working Group. Optimization and limitations of use of cryopreserved peripheral blood mononuclear cells for functional and phenotypic T-cell characterization. Clin Vaccine Immunol 2009; 16:1176 - 86; http://dx.doi.org/10.1128/CVI.00342-08; PMID: 19515870
   PubMed Web of Science ®Google Scholar